ANTAGONIST: PHARMACOLOGY AND PHARMACOKINETIC ENHANCER

Abstract

Antagonist is that the hormone therapy of choice in pre-menopausal estrogen receptor positive carcinoma in women and sometimes in post-menopausal women. The environmental and genetic factors widely affect the pharmacokinetic parameters of a drug and this effect is understood as pharmgeonetics. The pharmacokinetic parameters that are what a body does with the drug, like bioavailability, half-life, distribution and excretion, has primary importance within the medication of a disease. The pharmacodynamics parameters which elaborate what a drug does with the body like side effects and positive symptoms are the pillars of therapeutic outcome. thorough knowledge of both parameters is important to urge maximum benefits from a medication plan during a disease for instance carcinoma .